Tuesday's move came after Tilray announced the acquisition of another U.S.-based business on Monday. Investors also may be anticipating a boost for marijuana-related businesses after the U.S. election, as five more states have cannabis legalization questions on the ballot. Tilray announced Monday that it had bought New York-based craft brewer Montauk Brewing. Read More...
Motley Fool
Why Axsome Therapeutics Stock Is Bolting Higher Today
Axsome Therapeutics (NASDAQ: AXSM), a central nervous system disorder specialist, is having a good day today. Although Axsome’s management spent quite a bit of time discussing the commercial prospects of the excessive daytime sleepiness medication Sunosi during this latest earnings call, Wall Street and the company’s shareholders alike are primarily interested in the ongoing commercial launch of Auvelity. Auvelity, which was approved by the Food and Drug Administration earlier this year as a novel treatment for major depressive disorder, became commercially available on Oct. 20.
